ACETAMINOPHEN ACTIVATION BY HUMAN-LIVER CYTOCHROMES P450IIE1 AND P450IA2
ACETAMINOPHEN ACTIVATION BY HUMAN-LIVER CYTOCHROMES P450IIE1 AND P450IA2
复制标题
DOI:
10.1016/0003-9861(89)90278-6
复制
发表时间:
1989-06-01
影响因子:
3.9
通讯作者:
BLACK, M
中科院分区:
文献类型:
--
作者:
RAUCY, JL;LASKER, JM;BLACK, M
Acetaminophen (APAP), a widely used over-the-counter analgesic, is known to cause hepatotoxicity when ingested in large quantities in both animals and man, especially when administered after chronic ethanol consumption. Hepatotoxicity stems from APAP activation by microsomal P450 monooxygenases to a reactive metabolite that binds to tissue macromolecules, thereby initiating cellular necrosis. Alcohol consumption also causes the induction of P450IIE1, a liver microsomal enzyme that in reconstitution studies has proven to be an effective catalyst of APAP oxidation. Thus, elevated microsomal P450IIE1 levels could explain not only the kknown increase in APAP bioactivating activity of liver microsomes after prolonged ethanol ingestion but also the enhanced susceptibility to APAP toxicity. We therefore examined the role of P450IIE1 in human liver microsomal APAP activation. Our results indicate that two P450 isozymes, namely P450IIE1 and P450IA2, catalyze nearly all of the APAP activation in human liver microsomes. Since bioactivation of APAP is presumed to mediate its toxicity, then those factors affecting the hepatic levels of P450IIE1 (e.g., chronic alcohol consumption) and/or P450IA2 may markedly influence the susceptibility of certain individuals to APAP-promoted liver damage.